Korean OTC medicine · Reference information
Rejuvenex Cream
리쥬비넥스크림
- Category in Korea
- General (OTC) medicine (일반의약품, Korean category)
- Manufacturer / marketer
- PharmaResearch (파마리서치)
- Active ingredients and amounts
- In 1 g: Polydeoxyribonucleotide sodium 0.8mg
- MFDS item code
- 201405771
- Approval date in Korea
- Dec 5, 2014
Approved indications in Korea: "wounds and nutritional supplementation in conditions with insufficient nourishment of the skin and connective tissue, or conditions prone to ulceration due to insufficient nourishment".
Please note
- This medicine is approved in Korea; its approval status in other countries may differ. This page does not recommend buying or using it.
- The English text is our pharmacy's reference translation. The Korean original (the text approved by Korea's Ministry of Food and Drug Safety, MFDS) is authoritative. The translation neither recommends use nor indicates approval or approved indications in any other country.
- Korean law does not allow mail-order sales of medicines, so we do not sell medicines online or ship them.
- If you have a medical condition, are taking other medicines, are pregnant or breastfeeding, or the product is for a child, always consult a pharmacist.
Indications (as approved in Korea)
The English is our pharmacy's reference translation. It does not show indications approved in any other country.
Conditions with insufficient nourishment of the skin and connective tissue, or conditions prone to ulceration due to insufficient nourishment: wounds, nutritional supplementation
Show the Korean original
피부 및 결합조직의 영양부족 또는 영양부족으로 인한 궤양이 생기기 쉬운 질환: 상처, 영양보급
Dosage and administration (as approved in Korea)
The English is our pharmacy's reference translation. It does not show indications approved in any other country.
Apply an appropriate amount to the affected area 1–2 times a day, or administer as directed by a doctor.
Show the Korean original
환부에 1일 1~2회 적량 도포하거나, 의사의 지시에 따라 투여한다.
Precautions for use (as approved in Korea)
The English is our pharmacy's reference translation. It does not show indications approved in any other country.
1. The following persons should consult a doctor, dentist or pharmacist before using this medicine: persons with a history of hypersensitivity to this medicine or its ingredients
2. Precautions when using this medicine with other medicines: drug interactions and contraindications to concomitant use have not been studied.
3. Precautions when using this medicine: if a hypersensitivity reaction to an ingredient appears, stop administration and give appropriate treatment if necessary.
4. If too much of this medicine has been administered: no effects of overdose have been reported.
5. Adverse reactions that may occur with this medicine: if side effects occur, consult a doctor.
6. Storage precautions
a. Keep in an airtight container at room temperature.
b. Keep out of the reach of children.
c. Taking the medicine out of its original container and storing it in another container may cause serious accidents through misuse or reduce its quality, so always keep it in its original container.
Show the Korean original
1. 다음과 같은 사람은 이 약을 사용하기 전에 의사, 치과의사, 약사와 상의할 것: 이 약 및 이 약의 성분에 과민증의 병력이 있는 자
2. 이 약을 다른 약물과 병용할 경우 주의할 사항: 약물 상호작용이나 병용금기는 연구된 바 없다.
3. 이 약의 사용 시 주의할 사항: 성분에 과민반응이 나타날 경우, 투여를 중지하고 필요한 경우 적절한 처치를 한다.
4. 이 약을 과량 투여했을 경우: 과량투여로 인한 영향에 대해서는 보고된 바 없다.
5. 이 약으로 인해 일어날 수 있는 이상반응 : 부작용 발현 시 의사와 상의한다.
6. 저장상의 주의사항
가. 기밀용기, 실온보관을 준수
나. 어린이의 손이 닿지 않는 곳에 보관할 것
다. 의약품을 원래 용기에서 꺼내어 다른 용기에 보관하는 것은 의약품 오용에 따 른 큰 사고 발생이나 의약품 품질 저하의 원인이 될 수 있으므로 원래의 용기 에 꼭 넣고 보관할 것
Source: approval details on 의약품안전나라, the drug information site of Korea's Ministry of Food and Drug Safety (MFDS) (original page, checked Sep 21, 2026). Product images are taken from each manufacturer's or brand's official website, and the source is given for each image. If you hold the rights to an image and have concerns, please let us know and we will respond promptly.